The topic of real-world evidence (RWE) has gained considerable attention recently. As health researchers, policymakers, and regulators establish standards and structure for using real-world data (RWD) as evidence in regulatory and clinical decision making, patients must be the primary focus. Since the idea of RWD is new to many in the patient community, it is important to explore the patient community’s needs, concerns, and protentional contributions and use of RWE to ensure the patient voice is considered.
Methods & Principles
This ongoing project seeks to understand how patient-provided information (PPI) - gathered through meaningful patient engagement - can be translated by researchers into more patient-centered real-world data (RWD) research designs that reflect patients’ lived experiences.
In January 2019, Dr. Eleanor Perfetto spoke in a webinar with Jennifer Graff, Brande Yaist, and Tricia Lee Wilkins the FDA Framework for Real-World Evidence. You can access the webinar here.